par Wibmer, Thomas;Berghmans, Thierry ;Kropf, C;Lafitte, Jean-Jacques;Stoiber, KM;Paesmans, Marianne ;Ruediger, S;Scherpereel, Arnaud;Blanta, I;Rottbauer, W;Sculier, Jean-Paul ;Schumann, C
Référence European Respiratory Society Annual Congress(22: 01 AU 05-09-2012: Vienna), Histology as a potentil clinical prdictor of outcome in advanced non-small cell lung cancer treated with vinorelbine and mitomycin combination chemotherapy.
Publication Publié, 2012-09-01
Abstract de conférence
Titre:
  • Histology as a potentil clinical prdictor of outcome in advanced non-small cell lung cancer treated with vinorelbine and mitomycin combination chemotherapy.
Auteur:Wibmer, Thomas; Berghmans, Thierry; Kropf, C; Lafitte, Jean-Jacques; Stoiber, KM; Paesmans, Marianne; Ruediger, S; Scherpereel, Arnaud; Blanta, I; Rottbauer, W; Sculier, Jean-Paul; Schumann, C
Informations sur la publication:European Respiratory Society Annual Congress(22: 01 AU 05-09-2012: Vienna), Histology as a potentil clinical prdictor of outcome in advanced non-small cell lung cancer treated with vinorelbine and mitomycin combination chemotherapy.
Statut de publication:Publié, 2012-09-01
Sujet CREF:Sciences biomédicales
Langue:N/A